Skip to main content
Premium Trial:

Request an Annual Quote

Scimagix Agrees to Resell Compugen s Z3 Gel Analysis Tool

NEW YORK, Feb 21 – Scimagix, a Redwood Shores, Calif.-based bioinformatics company, said Wednesday it had agreed to serve as a reseller of Compugen’s Z3 system, which is used for analyzing 2-D electrophoresis gels.

Scimagix said it would sell Z3 along with its Scientific Image Management System, which stores, retrieves, and analyzes protein images. Scimagix and Compugen of Tel Aviv have also agreed to work together to integrate their products.

"Our agreement combines Compugen's extensive gel analysis methods with Scimagix's unique capability to search protein expression patterns," Robert Dunkle, CEO of Scimagix, said in a statement. "This high-throughput approach to analysis and mining of 2D gels is expected to accelerate proteomics research and drug discovery."

Financial terms were not disclosed.

Compugen’s Z3 uses proprietary algorithms and color overlay technology to compare 2-D gel separations of proteins from normal and diseased tissues.

Scimagix has also developed ProteinMine, a software tool that, like Z3, is designed to search 2-d gels according to size, shape, location, and intensity of protein spots, in order to find combinations of protein patterns and protein expression patterns. 

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.